Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory profiles of severe treatment-resistant depression
Rebecca Strawbridge, John Hodsoll, Timothy R. Powell, et al.
Journal of Affective Disorders (2018) Vol. 246, pp. 42-51
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

Peripheral blood inflammatory markers in depression: Response to electroconvulsive therapy and relationship with cognitive performance
Karen M. Ryan, Declan M. McLoughlin
Psychiatry Research (2022) Vol. 315, pp. 114725-114725
Open Access | Times Cited: 19
Association between peripheral inflammation and free-water imaging in Major Depressive Disorder before and after ketamine treatment – A pilot study
Mina Langhein, Johanna Seitz‐Holland, Amanda E. Lyall, et al.
Journal of Affective Disorders (2022) Vol. 314, pp. 78-85
Open Access | Times Cited: 18
GWAS linksAPOEto neuropsychiatric symptoms in mild cognitive impairment and dementia
Selina Vattathil, Freida Blostein, Tyne W. Miller‐Fleming, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review
Hui Xing, Xiaolei Liu, Yingying Zhang, et al.
Reviews in the Neurosciences (2025)
Closed Access
Computational Approaches for Uncovering Interoceptive Mechanisms in Psychiatric Disorders and Their Biological Basis
Marishka Mehta, Martin P. Paulus, Ryan Smith
Current topics in behavioral neurosciences (2025)
Closed Access
Adverse Effects and Safety of Antidepressants and Psychedelics for Depression in Cancer: A Systematic Review of Randomized Controlled Trials
Renan Massanobu Maekawa, Lorena Terene Lopes Guerra, José Carlos Bouso, et al.
Psychoactives (2025) Vol. 4, Iss. 1, pp. 6-6
Open Access
Major Depressive Disorder in Long COVID and Exposure to Pro‐Inflammatory Cytokines During Infection by SARS‐CoV‐2
Hernan Felipe Guillén-Burgos, Juan F Gálvez-Flórez, Sergio Moreno, et al.
Psychiatric Research and Clinical Practice (2025), pp. n/a-n/a
Open Access
Anti-inflammatory interventions for the treatment and prevention of depression among older adults: a systematic review and meta-analysis
Hong Gong, Wenjun Su, Shilong Deng, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Cellular immune phenotype of major depressive disorder – findings from the EMBARC study
Cherise R. Chin Fatt, Srividya Vasu, Nabila Haque, et al.
The World Journal of Biological Psychiatry (2025), pp. 1-10
Closed Access
Prognostic Implications of Depression and Inflammation in Patients With Metastatic Lung Cancer
Daniel C. McFarland, Rebecca M. Saracino, Andrew H. Miller, et al.
Future Oncology (2020) Vol. 17, Iss. 2, pp. 183-196
Open Access | Times Cited: 26
Sustained microglial activation in the area postrema of collagen-induced arthritis mice
Takayuki Matsushita, Kazuhiro Otani, Yohsuke Oto, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression
Ioana-Alexandra Dogaru, Maria Gabriela Puiu, Mirela Manea, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1403-1403
Open Access | Times Cited: 16
Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning
Yolanda Sánchez‐Carro, Alejandro de la Torre‐Luque, Itziar Leal‐Leturia, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110674-110674
Open Access | Times Cited: 15
Biological correlates of treatment resistant depression: a review of peripheral biomarkers
Emiliana Mancuso, Gaia Sampogna, Alessia Boiano, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
Cortisol-dependent impairment of dendrite plasticity in human dopaminergic neurons derived from hiPSCs is restored by ketamine: Relevance for major depressive disorders.
Laura Cavalleri, Irene Dassieni, G.S. Marcotto, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104049-104049
Open Access | Times Cited: 3
Psychological distress and uterine fibroids: a bidirectional two-sample mendelian randomization study
Xinyu Han, Tian qiang Wu, Yuanyuan Bian, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders
Pascal Barone
Behavioural Pharmacology (2019) Vol. 30, Iss. 2 and 3, pp. 163-186
Closed Access | Times Cited: 24
Keeping up with the clinical advances: depression
Renee‐Marie Ragguett, Jocelyn K. Tamura, Roger S. McIntyre
CNS Spectrums (2019) Vol. 24, Iss. S1, pp. 25-37
Closed Access | Times Cited: 24
Changes in interleukin-1 beta induced by rTMS are significantly correlated with partial improvement of cognitive dysfunction in treatment-resistant depression: a pilot study
Hiroshi Tateishi, Yoshito Mizoguchi, Atsushi Kawaguchi, et al.
Psychiatry Research (2020) Vol. 289, pp. 112995-112995
Closed Access | Times Cited: 22
Targeting the renin angiotensin system for the treatment of anxiety and depression
Sophocles Chrissobolis, Anh Luu, R. Waldschmidt, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173063-173063
Closed Access | Times Cited: 22
Is the Therapeutic Mechanism of Repetitive Transcranial Magnetic Stimulation in Cognitive Dysfunctions of Depression Related to the Neuroinflammatory Processes in Depression?
Hiroshi Tateishi, Yoshito Mizoguchi, Akira Monji
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 14
Inflammatory Proteins and Clinical Response to Psychological Therapy in Patients with Depression: An Exploratory Study
Rebecca Strawbridge, Lindsey Marwood, Sinéad King, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3918-3918
Open Access | Times Cited: 20
Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression
Xiaoping Wu, Biao Dai, Fanfan Yan, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 567-576
Open Access | Times Cited: 12
Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients
Onur Hurşıtoğlu, Ergül Belge Kurutaş, Rebecca Strawbridge, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110670-110670
Closed Access | Times Cited: 12
Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Incidence of Depression Among Older Cancer Survivors With Osteoarthritis: A Machine Learning Analysis
Nazneen Fatima Shaikh, Chan Shen, Traci LeMasters, et al.
Cancer Informatics (2023) Vol. 22
Open Access | Times Cited: 7

Scroll to top